-  - Zm. - Wolumen Bid- Ask- Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
-EUR - 0
Obrót: 0.00
-Wolumen Bid: - -Wolumen Ask: - 20,35 mldEUR - -

Opis działalności

Sonova, headquartered in Stäfa, Switzerland, is the leading manufacturer of innovative hearing care solutions. The Group operates through its core business brands Phonak, Unitron, Advanced Bionics and Connect Hearing. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants to wireless communication solutions. Founded in 1947, the Group is currently present in over 100 countries across the globe. Across all businesses, and by supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.
 

Zarząd & Rada nadzorcza

CEO
Arnd Kaldowski
Zarząd
Birgit Conix, Ludger Althoff, Robert Woolley, Lilika Beck, Oliver Lux, Katya Kruglova, Alistair Simpson
Rada nadzorcza
Robert F. Spoerry, Stacy Enxing Seng, Adrian Widmer, Lukas Braunschweiler, Lynn Dorsey Bleil, Roland Diggelmann, Ronald van der Vis, Julie Tay, Gilbert Achermann, Gregory Behar
 

Dane firmy

Nazwa: Sonova Holding AG
Adres: Laubisrütistraße 28,CH-8712 Stäfa
Telefon: +41-58-928-0101
Fax: +41-58-928-2011
E-mail: info@sonova.com
Internet: www.sonova.com
Przemysł: Służba zdrowia
Sektor: Dostawca Usług Medycznych
Podsektor: Opieka Zdrowotna
Koniec roku finansowego: 31.03
Free float: 79,40%
Data IPO: 01.11.1994

Relacje inwestorskie

Nazwa: Thomas Bernhardsgrütter
Telefon: +41-58-928-3344
Fax: +41 (58) 928 3399
E-mail: ir@sonova.com

Główni akcjonariusze

Inne
 
71,38%
Beda Diethelm and Annamaria Diethelm-Pandiani
 
11,26%
Family of Hans-Ueli Rihs
 
6,18%
BlackRock, Inc.
 
5,10%
UBS Fund Management AG
 
3,06%
MFS Investment Management
 
3,02%